Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
Robert N. Foley,Patrick S. Parfrey,Janet Morgan,Paul E. Barre,Patricia Campbell,Pierre Cartier,Douglas Coyle,Adrian Fine,Paul Handa,Iris Kingma,Cathy Y. Lau,Adeera Levin,David C. Mendelssohn,Norman Muirhead,T. Brendan Murphy,Richard K. Plante,Gerald A. Posen,George A. Wells +17 more
TLDR
Normalization of hemoglobin does not lead to regression of established concentric LV hypertrophy or LV dilation, and it may, however, prevent the development of LV dilated and it leads to improved quality of life.About:
This article is published in Kidney International.The article was published on 2000-09-01 and is currently open access. It has received 394 citations till now. The article focuses on the topics: End stage renal disease.read more
Citations
More filters
Journal ArticleDOI
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
Ajay K. Singh,Lynda A. Szczech,Kezhen L. Tang,Huiman X. Barnhart,Shelly Sapp,Marsha Wolfson,Donal N. Reddan,Abstr Act +7 more
TL;DR: The use of a target hemoglobin level of 13.5 g per deciliter (as compared with 11.3 g perDeciliter) was associated with increased risk and no incremental improvement in the quality of life and the use of epoetin alfa targeted to achieve a level of 11.4 g perdeciliter was not associated with an increased risk.
Journal ArticleDOI
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
Tilman B. Drüeke,Francesco Locatelli,Naomi Clyne,Kai-Uwe Eckardt,Iain C. Macdougall,Dimitrios Tsakiris,Hans-Ulrich Burger,Armin Scherhag +7 more
TL;DR: In patients with chronic kidney disease, early complete correction of anemia does not reduce the risk of cardiovascular events and there was no significant difference in the combined incidence of adverse events between the two groups.
Journal Article
K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.
TL;DR: Cardiovascular Disease in Dialysis Patients Tables: An Overview of Epidemiology of Cardiovascular disease in Children and Work Group Members and Foreword.
Journal ArticleDOI
Epidemiology of cardiovascular disease in chronic renal disease
TL;DR: The risk of cardiovascular disease in patients with chronic renal disease appears to be far greater than in the general population as mentioned in this paper, even after stratification by age, gender, race, and the presence or absence of diabetes.
Journal ArticleDOI
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.
TL;DR: This chapter discusses clinical practice guidelines and recommendations for treatment of anemia in children and adults with Kidney Kidney disease, as well as specific cases of patients with HD-CKD.
References
More filters
Journal ArticleDOI
The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.
TL;DR: In this article, cross-sectional data from the Medical Outcomes Study (MOS) were analyzed to test the validity of the MOS 36-Item Short-Form Health Survey (SF-36) scales as measures of physical and mental health constructs.
Journal ArticleDOI
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
TL;DR: The survey shows significant interobserver and interlaboratory variation in measurement when examining the same echoes and indicates a need for ongoing education, quality control and standardization of measurement criteria.
Journal ArticleDOI
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.
Anatole Besarab,W K Bolton,J K Browne,Joan C. Egrie,Allen R. Nissenson,D M Okamoto,Steve J. Schwab,David A. Goodkin +7 more
TL;DR: In patients with clinically evident congestive heart failure or ischemic heart disease who are receiving hemodialysis, administration of epoetin to raise their hematocrit to 42 percent is not recommended.
Journal ArticleDOI
Epidemiology of cardiovascular disease in chronic renal disease
TL;DR: The risk of cardiovascular disease in patients with chronic renal disease appears to be far greater than in the general population as mentioned in this paper, even after stratification by age, gender, race, and the presence or absence of diabetes.
Journal Article
Epidemiology of cardiovascular disease in chronic renal disease.
TL;DR: Patients with chronic renal disease should be considered in the highest risk group for subsequent cardiovascular events, and patients who develop clinical manifestations of cardiac failure should be evaluated for cardiovascular disease.